Download Citation
Article Source:
Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial
Holbrook R,
Higuera L,
Wherry K,
Phay D,
Hsieh YC,
et al.
(2020)
Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial.
PLOS ONE 15(11): e0241697.
https://doi.org/10.1371/journal.pone.0241697